Integrating network pharmacology and experimental validation to clarify the anti-hyperuricemia mechanism of cortex phellodendri in mice
Hyperuricemia (HUA), a common metabolic disease, is treated as the second-largest metabolic disease after diabetes in China. Cortex Phellodendri (CP) is one of the most frequently used herbal medicines for treating gout or HUA. However, the mechanism underlying the anti-HUA effect of CP is still unr...
Main Authors: | Lieqiang Xu, Juanjuan Cheng, Jieyi Lu, Guoshu Lin, Qiuxia Yu, Yucui Li, Jiannan Chen, Jianhui Xie, Ziren Su, Qi Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.964593/full |
Similar Items
-
Anti-Inflammatory Activation of Phellodendri Chinensis Cortex is Mediated by Berberine Erythrocytes Self-Assembly Targeted Delivery System
by: Li M, et al.
Published: (2022-12-01) -
Long-Term Phellodendri Cortex Supplementation in the Tiger Grouper (<i>Epinephelus fuscoguttatus</i>): Dual Effects on Intestinal Health Revealed by Transcriptome Analysis
by: Yan Cai, et al.
Published: (2023-12-01) -
Green Phellodendri Chinensis Cortex-based carbon dots for ameliorating imiquimod-induced psoriasis-like inflammation in mice
by: Meiling Zhang, et al.
Published: (2021-04-01) -
Anti-hyperuricemia effect of hesperetin is mediated by inhibiting the activity of xanthine oxidase and promoting excretion of uric acid
by: Meng-Fei An, et al.
Published: (2023-04-01) -
Uricosuric effect of dandelion root extract on oxonate-induced hyperuricemia in rats
by: Khairullah M. Khallawi, et al.
Published: (2023-08-01)